Chief Scientific Officer: Ray Suhandynata is a board-certified clinical chemist through the American Board of Clinical Chemistry and National Registry of Certified Chemists.
His recent work has covered a number of areas, including:
- Investigation and validation of SARS-CoV-2 serology assays in the clinical laboratory, Development of novel rapid mass spectrometry (MS) based approach to detect antibiotic resistant bacteria
- Identification of novel psychoactive substances, and
- Development/validation of MS assays for the measurement of cannabinoids, drugs of abuse, and therapeutic drug monitoring
Currently, Dr. Suhandynata holds a position as an Assistant Professor at the University of California San Diego – Skaggs School of Pharmacy and Pharmaceutical Sciences and Department of Pathology.
Saba’s vast experience from his time in the military, as well as civilian life, provides him with a unique perspective on business issues.
Dr. Suhandynata has diversified his scientific portfolio by operating as a key opinion leader and scientific consultant for contract research organizations in the biopharmaceutical space, with a focus on portfolios operating under good manufacturing/laboratory practices (GMP/GLP).
As a founding member, Dr. Suhandynata brings more than a decade of scientific experience and a track-record of scientific rigor to facilitate the success of Sequence Sciences. His attention to detail and training as a board-certified clinical chemist ensure the accuracy and robustness for all assays developed and implemented by the company.
Get a Quote
Need a high-quality biostorage facility for your critical specimens? We got that.